HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis

• DOI: 10.1080/2162402x.2024.2356942
• Publication Date: 2024-05-20T09:07:35Z
• Authors: Muyuan You; Minjie Fu; Zhewei Shen; Yuan Feng; Licheng Zhang; Xianmin Zhu; Zhengping Zhuang; Ying Mao; Wei Hua
• Keywords: 0301 basic medicine; Lung Neoplasms; Mice; 03 medical and health sciences; Cancer-Associated Fibroblasts; Cell Line, Tumor; Basic Helix-Loop-Helix Transcription Factors; Tumor Microenvironment; HIF; tumor microenvironment; Humans; Animals; Cell Lineage; RC254-282; Original Research; Neovascularization, Pathologic; Brain Neoplasms; Brain metastasis; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC581-607; Gene Expression Regulation, Neoplastic; lung cancer; Phenotype; Immunologic diseases. Allergy; Single-Cell Analysis

Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets.